CmaxInsight Market Intelligence: Market Research Reports

... within 1-2 Business Days. CmaxInsight’s, “D1 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the D1 Antagonist. Pipeline Covered: This section mentions all the promising therapies ...

... within 1-2 Business Days. CmaxInsight’s, “D2 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the D2 Agonist. Pipeline Covered: This section mentions all the promising therapies in ...

... within 1-2 Business Days. CmaxInsight’s, “D3 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the D3 Agonist. Pipeline Covered: This section mentions all the promising therapies in ...

... within 1-2 Business Days. CmaxInsight’s, “D3 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the D3 Antagonist. Pipeline Covered: This section mentions all the promising therapies ...

... within 1-2 Business Days. CmaxInsight’s, “D4 Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the D4 Agonist. Pipeline Covered: This section mentions all the promising therapies in ...

... within 1-2 Business Days. CmaxInsight’s, “D4 Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the D4 Antagonist. Pipeline Covered: This section mentions all the promising therapies ...

... within 1-2 Business Days. CmaxInsight’s, “Delta Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Delta Antagonist. Pipeline Covered: This section mentions all the promising ...

... coverage of MoA enables the client to understand the landscape of the Diglyceride Acyltransferase (DGAT) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

... coverage of MoA enables the client to understand the landscape of the Dihydroorotate Dehydrogenase (DHODH) Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

... coverage of MoA enables the client to understand the landscape of the DNA-Dependent RNA Polymerase Inhibitor. Pipeline Covered: This section mentions all the promising therapies in different ...

... within 1-2 Business Days. CmaxInsight’s, “Dopaminergic Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... the client to understand the landscape of the Dopaminergic Agonist. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Dopaminergic system Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Dopaminergic system Antagonist. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Estrogen Receptor Beta Partial Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Estrogen Receptor Beta Partial Agonist R&D Please note: Certain sections in the ...

... Days. CmaxInsight’s, “Factor II (Prothrombin) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Factor II (Prothrombin) Inhibitor. Pipeline Covered: This section mentions all the promising ...

... Days. CmaxInsight’s, “Factor IIa (Thrombin) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Factor IIa (Thrombin) Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Factor IX-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action (MoA ... the client to understand the landscape of the Factor IX. Pipeline Covered: This section mentions all the promising therapies ...

... Business Days. CmaxInsight’s, “Factor IX A Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... enables the client to understand the landscape of the Factor IX A Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... 1-2 Business Days. CmaxInsight’s, “Factor VIIa Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Factor VIIa Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... clients within 1-2 Business Days. CmaxInsight’s, “Farnesoid X Receptor (FXR) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Farnesoid X Receptor (FXR) Agonist R&D Please note: Certain sections in the ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Fatty Acid Amide Hydrolase (FAAH) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Fatty Acid Amide Hydrolase (FAAH) Inhibitor to enhance and expand business potential ...

... clients within 1-2 Business Days. CmaxInsight’s, “Fatty Acid Synthase (FAS) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Fatty Acid Synthase (FAS) Inhibitor R&D Please note: Certain sections in the ...

... 1-2 Business Days. CmaxInsight’s, “Fc-Gamma Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the Fc-Gamma Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

... to the clients within 1-2 Business Days. CmaxInsight’s, “Fibroblast Activation Protein (FAP or Seprase) Inhibitor-Pipeline Intelligence, 2019”, report provides ... by identifying potential partners with progressing projects for Fibroblast Activation Protein (FAP or Seprase) Inhibitor to enhance and expand ...

... clients within 1-2 Business Days. CmaxInsight’s, “Fibroblast Growth Factor (FGF) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Fibroblast Growth Factor (FGF) Inhibitor R&D Please note: Certain sections in the ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Fibroblast Growth Factor 1 (FGF-1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Fibroblast Growth Factor 1 (FGF-1) Inhibitor to enhance and expand business potential ...

... to the clients within 1-2 Business Days. CmaxInsight’s, “Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor-Pipeline Intelligence, 2019”, report provides ... by identifying potential partners with progressing projects for Fibroblast Growth Factor Receptor 4 (FGFR4) Inhibitor to enhance and expand ...

... clients within 1-2 Business Days. CmaxInsight’s, “Focal Adhesion Kinase (FAK) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... leading companies Assess challenges and opportunities that influence Focal Adhesion Kinase (FAK) Inhibitor R&D Please note: Certain sections in the ...

... within 1-2 Business Days. CmaxInsight’s, “Fusion Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Fusion Inhibitor. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “G2 Checkpoint Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... client to understand the landscape of the G2 Checkpoint Inhibitor. Pipeline Covered: This section mentions all the promising therapies ...

... 1-2 Business Days. CmaxInsight’s, “GABA Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the GABA Receptor Agonist. Pipeline Covered: This section mentions all the promising therapies ...

... 1-2 Business Days. CmaxInsight’s, “GABA Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the GABA Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “GABA Receptor Modulators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the GABA Receptor Modulators. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “GABA Transaminase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the GABA Transaminase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “GABAA Modulators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the GABAA Modulators. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “GABAB Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the GABAB Agonist. Pipeline Covered: This section mentions all the promising therapies ...

... within 1-2 Business Days. CmaxInsight’s, “Galectin Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Galectin Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Gamma Secretase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Gamma Secretase Inhibitor. Pipeline Covered: This section mentions all the promising ...

... 1-2 Business Days. CmaxInsight’s, “Ghrelin Receptor Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Ghrelin Receptor Agonist. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Glucagon Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Glucagon Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

... Days. CmaxInsight’s, “Glucagon-Like Peptide (GLP) Agonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... the client to understand the landscape of the Glucagon-Like Peptide (GLP) Agonist. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Glucocorticoid induced tumor necrosis factor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... companies Assess challenges and opportunities that influence Glucocorticoid induced tumor necrosis factor R&D Please note: Certain sections in the ...

... coverage of MoA enables the client to understand the landscape of the Glucocorticoid Receptor (GR) Antagonist. Pipeline Covered: This section mentions all the promising therapies in different ...

... within 1-2 Business Days. CmaxInsight’s, “Glucokinase Activators-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ... client to understand the landscape of the Glucokinase Activators. Pipeline Covered: This section mentions all the promising ...

... Business Days. CmaxInsight’s, “Glucosylceramide Synthase Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism ... client to understand the landscape of the Glucosylceramide Synthase Inhibitor. Pipeline Covered: This section mentions all the ...

... Business Days. CmaxInsight’s, “Glutamate Receptor Antagonist-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of ... the client to understand the landscape of the Glutamate Receptor Antagonist. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Glycan Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the Glycan Inhibitor. Pipeline Covered: This section mentions all the promising ...

... clients within 1-2 Business Days. CmaxInsight’s, “Glycine Transporter Type-1 (Glyt-1) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive ... companies Assess challenges and opportunities that influence Glycine Transporter Type-1 (Glyt-1) Inhibitor R&D Please note: Certain sections in the ...

... the clients within 1-2 Business Days. CmaxInsight’s, “Glycogen Synthase Kinase 3 (GSK-3) Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights ... identifying potential partners with progressing projects for Glycogen Synthase Kinase 3 (GSK-3) Inhibitor to enhance and expand business potential ...

... within 1-2 Business Days. CmaxInsight’s, “GM-CSF Inhibitor-Pipeline Intelligence, 2019”, report provides comprehensive insights about pipeline drugs across this mechanism of action ( ... the client to understand the landscape of the GM-CSF Inhibitor. Pipeline Covered: This section mentions all the promising ...

... within 1-2 Business Days. CmaxInsight’s, “Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist-Pipeline Intelligence, 2019”, report provides ... partners with progressing projects for Gonadotropin-Releasing Hormone (GnRH) Receptor (LHRH Receptor) Antagonist to enhance and expand ...